Content area
Full Text
A 47-year-old woman developed Pisa syndrome (pleurothotonus) during treatment with sertraline for obsessive-compulsive symptoms, and quetiapine for persistent psychotic symptoms.
The woman, who was diagnosed with schizophrenia, obsessive-compulsive disorder and mental retardation began receiving quetiapine 800 mg/day [route and duration of treatment to reaction onset not stated] during a hospitalisation for a severe psychotic relapse. A month later, her obsessive-compulsive symptoms had worsened; sertraline was...